Evidence method
Level · gp.fundamentals.capex_revenue_ratio
3.93% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
DXCM · Sep 30, 2026
DEXCOM INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration
State dimensions
Filing0001093557-26-000195General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
24.22% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
11.18% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
57.32% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
64.29% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
24.34% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
12.02% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
2.74% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History21 statesSelf-history eligible
Mar 31, 20190/7 normalizedLevel 3Jun 30, 20190/7 normalizedLevel 3Sep 30, 20190/7 normalizedLevel 3Dec 31, 20190/8 normalizedLevel 3Mar 31, 20200/8 normalizedLevel 3Jun 30, 20200/8 normalizedLevel 3Sep 30, 20200/8 normalizedLevel 3Dec 31, 20207/8 normalizedLevel 3Mar 31, 20217/8 normalizedLevel 3Jun 30, 20217/8 normalizedLevel 3Sep 30, 20217/8 normalizedLevel 3Dec 31, 20218/8 normalizedLevel 3Mar 31, 20228/8 normalizedLevel 3Jun 30, 20228/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/8 normalizedLevel 3Mar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Sep 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 6.47%
- Current
- 3.93%
- Delta
- -2.54%
- Previous
- 20.57%
- Current
- 24.22%
- Delta
- 3.64%
- Previous
- 13.08%
- Current
- 11.18%
- Delta
- -1.90%
- Previous
- 55.52%
- Current
- 57.32%
- Delta
- 1.80%
- Previous
- 63.44%
- Current
- 64.29%
- Delta
- 0.86%
- Previous
- 24.33%
- Current
- 24.34%
- Delta
- 0.01%
- Previous
- 11.69%
- Current
- 12.02%
- Delta
- 0.33%
- Previous
- 2.98%
- Current
- 2.74%
- Delta
- -0.24%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
- Similarity
- 88%
- Compared
- 8 dimensions
- Coverage
- 100%
- Similarity
- 77%
- Compared
- 8 dimensions
- Coverage
- 100%
- Similarity
- 72%
- Compared
- 8 dimensions
- Coverage
- 100%
- Similarity
- 71%
- Compared
- 8 dimensions
- Coverage
- 100%
- Similarity
- 68%
- Compared
- 8 dimensions
- Coverage
- 100%
Research Graph
Related governed research
Analogous To · DXCM state analogue 1 →Analogous To · DXCM state analogue 5 →Analogous To · DXCM state analogue 2 →Compared To · Surgical & Medical Instruments & Apparatus peers →Analogous To · DXCM state analogue 3 →Analogous To · DXCM state analogue 4 →Derived From · DXCM Company Quality Vector →Has State · DEXCOM INC →Transitioned To · DXCM CAPEX_INTENSITY_DECREASED →Transitioned To · DXCM CASH_GENERATION_INCREASED →Transitioned To · DXCM GROWTH_DECREASED →Transitioned To · DXCM INVENTORY_PRESSURE_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.